Gender effect on the accumulation of hyperphosphorylated tau in the brain of locus-ceruleus-injured APP-transgenic mouse

Neuroscience Letters

Volumn 468, Issue 3, 2010, Pages 243-247

  Oikawa, Naoto ^a   Ogino, Koichi ^b   Masumoto, Takumi ^b   Yamaguchi, Haruyasu ^c   Yanagisawa, Katsuhiko ^a  

^a NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^b OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^c GUNMA UNIVERSITY   (Japan)

Author keywords

Alzheimer disease; Amyloid protein; Locus ceruleus; Noradrenaline; Tau; Tau phosphorylation; Testosterone

Indexed keywords

2 BROMO N (2 CHLOROETHYL) N ETHYLBENZYLAMINE; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BRAIN CORTEX; CONTROLLED STUDY; FEMALE; LOCUS CERULEUS; MALE; MOUSE; NERVE CELL DEGENERATION; NEUROFIBRILLARY TANGLE; NONHUMAN; NORADRENALIN BRAIN LEVEL; NORADRENERGIC NERVE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SEX DIFFERENCE; TESTOSTERONE RELEASE; TRANSGENIC MOUSE; WESTERN BLOTTING;

AMYLOID; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BENZYLAMINES; BRAIN; FEMALE; LOCUS COERULEUS; MALE; MICE; MICE, TRANSGENIC; NEURONS; NOREPINEPHRINE; PHOSPHORYLATION; SEX FACTORS; TAU PROTEINS; TESTOSTERONE;

EID: 72249091681     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.11.005     Document Type: Article

References (41)

1. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B.L., Finch C.E., Frautschy S., Griffin W.S.T., Hampel H., Hull M., Landreth G., Lue L.F., Mrak R., Mackenzie I.R., McGeer P.L., O'Banion M.K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., Van Muiswinkel F.L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., and Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol. Aging 21 (2000) 383-421
2. Bondareff W., Mountjoy C.Q., Roth M., Rossor M.N., Iversen L.L., Reynolds G.P., and Hauser D.L. Neuronal degeneration in locus ceruleus and cortical correlates of Alzheimer disease. Alzheimer Dis. Assoc. Disord. 1 (1987) 256-262
3. Chang K.A., Kim H.S., Ha T.Y., Ha J.W., Shin K.Y., Jeong Y.H., Lee J.P., Park C.H., Kim S., Baik T.K., and Suh Y.H. Phosphorylation of amyloid precursor protein (APP) at Thr668 regulates the nuclear translocation of the APP intracellular domain and induces neurodegeneration. Mol. Cell. Biol. 26 (2006) 4327-4338
4. Conner J.M., Lauterborn J.C., Yan Q., Gall C.M., and Varon S. Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. J. Neurosci. 17 (1997) 2295-2313
5. Dudley M.W., Howard B.D., and Cho A.K. The interaction of the beta-haloethyl benzylamines, xylamine, and DSP-4 with catecholaminergic neurons. Annu. Rev. Pharmacol. Toxicol. 30 (1990) 387-403
6. Elliott E., Atlas R., Lange A., and Ginzburg I. Brain-derived neurotrophic factor induces a rapid dephosphorylation of tau protein through a PI-3Kinase signalling mechanism. Eur. J. Neurosci. 22 (2005) 1081-1089
7. Fawcett J.P., Bamji S.X., Causing C.G., Aloyz R., Ase A.R., Reader T.A., McLean J.H., and Miller F.D. Functional evidence that BDNF is an anterograde neuronal trophic factor in the CNS. J. Neurosci. 18 (1998) 2808-2821
8. Feinstein D.L., Heneka M.T., Gavrilyuk V., Russo C.D., Weinberg G., and Gaela E. Noradrenergic regulation of inflammatory gene expression in brain. Neurochem. Int. 41 (2002) 357-365
9. Flament S., Delacourte A., Hémon B., and Défossez A. Characterization of two pathological tau protein, variants in Alzheimer brain cortices. J. Neurol. Sci. 92 (1989) 133-141
10. German D.C., Manaye K.F., White III C.L., Woodward D.J., McIntire D.D., Smith W.K., Kalaria R.N., and Mann D.M.A. Disease-specific patterns of locus coeruleus cell loss. Ann. Neurol. 32 (1992) 667-676
11. Grudzien A., Shaw P., Weintraub S., Bigio E., Mash D.C., and Mesulam M.M. Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer's disease. Neurobiol. Aging 28 (2007) 327-335
12. Grundke-Iqbal I., Iqbal K., Quinlan M., Tung Y.C., Zaidi M.S., and Wisniewski H.M. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J. Biol. Chem. 261 (1986) 6084-6089
13. Heneka M.T., Ramanathan M., Jacobs A.H., Dumitrescu-Ozimek L., Bilkei-Gorzo A., Debeir T., Sastre M., Galldiks N., Zimmer A., Hoehn M., Heiss W.D., Klockgether T., and Staufenbiel M. Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice. J. Neurosci. 26 (2006) 1343-1354
14. Hooper C., Killick R., and Lovestone S. The GSK3 hypothesis of Alzheimer's disease. J. Neurochem. 104 (2008) 1433-1439
15. Ida N., Hartmann T., Pantel J., Schröder J., Zerfass R., Förstl H., Sandbrink R., Masters C.L., and Beyreuther K. Analysis of heterogeneous βA4 peptides in human cerebrospinal fluid and blood by newly developed sensitive western blot assay. J. Biol. Chem. 271 (1996) 22908-22914
16. Ihara Y., Nukina N., Miura R., and Ogawara M. Phosphorylated tau protein is integrated into paired helical filaments in Alzheimer's disease. J. Biochem. 99 (1986) 1807-1810
17. Itoi K. Ablation of the central noradrenergic neurons for unraveling their roles in stress and anxiety. Ann. N. Y. Acad. Sci. 1129 (2008) 47-54
18. Kalinin S., Gavrilyuk V., Polak P.E., Vasser R., Zhao J., Heneka M.T., and Feinstein D.L. Noradrenaline deficiency in brain increases β-amyloid plaque burden in an animal model of Alzheimer's disease. Neurobiol. Aging 28 (2007) 1206-1214
19. Lee M.S., Kao S.C., Lemere C.A., Xia W., Tseng H.C., Zhou Y., Neve R., Ahlijanian M.K., and Tsai L.H. APP processing is regulated by cytoplasmic phosphorylation. J. Cell. Biol. 163 (2003) 83-95
20. Lee V.M., Balin B.J., Otvos Jr. L., and Trojanowski J.Q. A68: a major subunit of paired helical filaments and derivatized forms of normal tau. Science 251 (1991) 675-678
21. Li Y., Liu L., Barger S.W., and Griffin W.S.T. Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway. J. Neurosci. 23 (2003) 1605-1611
22. Loughlin S.E., Foote S.L., and Fallon J.H. Locus coeruleus projections to cortex: topography, morphology and collateralization. Brain Res. Bull. 9 (1982) 287-294
23. Mai L., Jope R.S., and Li X. BDNF-mediated signal transduction is modulated by GSK3β and mood stabilizing agents. J. Neurochem. 82 (2002) 75-83
24. Marcyniuk B., Mann D.M.A., and Yates P.O. The topography of cell loss from locus caeruleus in Alzheimer's disease. J. Neurol. Sci. 76 (1986) 335-345
25. Miyasaka T., Morishima-Kawashima M., Ravid R., Kamphorst W., Nagashima K., and Ihara Y. Selective deposition of mutant tau in the FTDP-17 brain affected by the P301L mutation. J. Neuropathol. Exp. Neurol. 60 (2001) 872-884
26. Mori H., Takio K., Ogawara M., and Selkoe D.J. Mass spectrometry of purified amyloid β protein in Alzheimer's disease. J. Biol. Chem. 267 (1992) 17082-17086
27. Morishima-Kawashima M., Oshima N., Ogata H., Yamaguchi H., Yoshimura M., Sugihara S., and Ihara Y. Effect of apolipoprotein E allele ε4 on the initial phase of amyloid β-protein accumulation in the human brain. Am. J. Pathol. 157 (2000) 2093-2099
28. Nakaya T., and Suzuki T. Role of APP phosphorylation in Fe65-dependent gene transactivation mediated by AICD. Genes Cells 11 (2006) 633-645
29. 2-terminal kinase and concomitantly abolishes hyperphosphorylation of τ: implications for Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 1140-1145
30. Papasozomenos S.C., and Papasozomenos H. The activation of heat shock transcription factor 1 is differentially regulated in the brain of estrogen- and testosterone-treated heat-shocked rats. J. Alzheimers Dis. 15 (2008) 375-390
31. Pugh P.L., Vidgeon-Hart M.P., Ashmeade T., Culbert A.A., Seymour Z., Perren M.J., Joyce F., Bate S.T., Babin A., Virley D.J., Richardson J.C., Upton N., and Sunter D. Repeated administration of the noradrenergic neurotoxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) modulates neuroinflammation and amyloid plaque load in mice bearing amyloid precursor protein and presenilin-1 mutant transgenes. J. Neuroinflammation 5 8 (2008)
32. Roher A.E., Lowenson J.D., Clarke S., Wolkow C., Wang R., Cotter R.J., Reardon I.M., Zürcher-Neely H.A., Heinrikson R.L., Ball M.J., and Greenberg B.D. Structural alterations in the peptide backbone of β-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J. Biol. Chem. 268 (1993) 3072-3083
33. Sheng J.G., Jones R.A., Zhou X.Q., McGinness J.M., Van Eldik L.J., Mrak R.E., and Griffin W.S.T. Interleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer's disease: potential significance for tau protein phosphorylation. Neurochem. Int. 39 (2001) 341-348
34. + astrocytes with neurofibrillary tangle stages. J. Neuropathol. Exp. Neurol. 56 (1997) 285-290
35. Shin R.W., Ogino K., Shimabuku A., Taki T., Nakashima H., Ishihara T., and Kitamoto T. Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Aβ and tau. Acta Neuropathol. 113 (2007) 627-636
36. Tomlinson B.E., Irving D., and Blessed G. Cell loss in the locus coeruleus in senile dementia of Alzheimer type. J. Neurol. Sci. 49 (1981) 419-428
37. Walsh D.M., and Selkoe D.J. Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 44 (2004) 181-193
38. Waterhouse B.D., Lin C.S., Burne R.A., and Woodward D.J. The distribution of neocortical projection neurons in the locus coeruleus. J. Comp. Neurol. 10 (1983) 418-431
39. Xu Y.F., Zhang Y.J., Zhang A.H., Zhang Q., Wu T., and Wang J.Z. Attenuation of okadaic acid-induced hyperphosphorylation of cytoskeletal proteins by heat preconditioning and its possible underlying mechanisms. Cell Stress Chaperones 9 (2004) 304-312
40. Yuyama K., Yamamoto N., and Katsuhiko K. Chloroquine-induced endocytic pathway abnormalities: cellular model of GM1 ganglioside-induced Aβ fibrillogenesis in Alzheimer's disease. FEBS Lett. 580 (2006) 6972-6976
41. Zarow C., Lyness S.A., Mortimer J.A., and Chui H.C. Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Arch. Neurol. 60 (2003) 337-341